Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Deferred Taxes (2016 - 2021)

ImmunityBio (IBRX) has disclosed Deferred Taxes for 6 consecutive years, with -$8000.0 as the latest value for Q4 2021.

  • Quarterly Deferred Taxes rose 96.14% to -$8000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$8000.0 through Dec 2021, up 99.73% year-over-year, with the annual reading at -$4000.0 for FY2022, 50.0% up from the prior year.
  • Deferred Taxes for Q4 2021 was -$8000.0 at ImmunityBio, up from -$207000.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $38000.0 in Q2 2020, with the low at -$1.7 million in Q3 2020.
  • Average Deferred Taxes over 5 years is -$282071.4, with a median of -$124000.0 recorded in 2017.
  • The sharpest move saw Deferred Taxes plummeted 2487.5% in 2020, then surged 96.14% in 2021.
  • Over 5 years, Deferred Taxes stood at -$182000.0 in 2017, then surged by 32.97% to -$122000.0 in 2018, then surged by 93.44% to -$8000.0 in 2019, then tumbled by 2487.5% to -$207000.0 in 2020, then soared by 96.14% to -$8000.0 in 2021.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$8000.0, -$207000.0, and -$1.7 million for Q4 2021, Q4 2020, and Q3 2020 respectively.